Literature DB >> 33468248

Avoiding a Med-Wreck: a structured medication reconciliation framework and standardized auditing tool utilized to optimize patient safety and reallocate hospital resources.

Ali Elbeddini1, Sarah Almasalkhi2, Thulasika Prabaharan2, Cindy Tran2, Mohamed Gazarin3, Ahmed Elshahawi4.   

Abstract

BACKGROUND: The incidence of preventable adverse drug events (ADE) is approximately one medication error per patient per hospital-day. A quality medication reconciliation (MedRec) process is a crucial intervention used to reduce ADE in the hospital and community setting. Amid the coronavirus disease 2019 (COVID-19) pandemic, preventing medication errors is vital to avoid patient readmission, reduce disease complications, and reduce cost and patient burden on the healthcare system.
OBJECTIVES: To develop a standardized MedRec framework that can be implemented in all healthcare settings to reduce patient and staff harm during COVID-19. Also, to create a standardized auditing tool used to assess the quality of the MedRec process and allow for continuous quality improvement.
METHODS: A multi-site gap analysis (MGA) was performed to collect observational data that were collected from four different healthcare sites (two hospitals, a long-term care facility, and a community pharmacy). MGA consists of collecting data across several sites which answer a standardized questionnaire. A standardized MedRec framework and auditing tool were developed based on the gaps observed in each site and literature reviews.
RESULTS: A standardized MedRec process was not implemented in any of the observed sites. The healthcare sites lacked a designated MedRec team and training related to the MedRec process leading to multiple discrepancies at discharge. Patients were not counselled on changes to home medications, and a discharge report was often not provided upon discharge. Communication mechanisms between community pharmacies and hospital physicians are not available or easily accessible.
CONCLUSION: The proposed structured MedRec framework is vital to reduce medication errors and patient harm amid COVID-19. Moreover, the comprehensive auditing tool developed in this study allows for continuous quality improvement resulting in superior quality care, reduction of workflow inefficiencies, cost savings on hospital readmissions, and overall enhanced healthcare system performance.

Entities:  

Keywords:  Auditing tool; COVID-19; Cost-effective analysis; Medication errors; Medication reconciliation

Year:  2021        PMID: 33468248      PMCID: PMC7814270          DOI: 10.1186/s40545-021-00296-w

Source DB:  PubMed          Journal:  J Pharm Policy Pract        ISSN: 2052-3211


  12 in total

1.  Medication reconciliation in the acute care setting: opportunity and challenge for nursing.

Authors:  Carol Sullivan; Kristine M Gleason; Denise Rooney; Jennifer M Groszek; Cynthia Barnard
Journal:  J Nurs Care Qual       Date:  2005 Apr-Jun       Impact factor: 1.597

Review 2.  Organisational culture: an important concept for pharmacy practice research.

Authors:  Shane Scahill; Jeff Harrison; Peter Carswell; Zaheer-Ud-Din Babar
Journal:  Pharm World Sci       Date:  2009-08-07

3.  Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients.

Authors:  Hilary Hamilton; Paul Gallagher; Cristin Ryan; Stephen Byrne; Denis O'Mahony
Journal:  Arch Intern Med       Date:  2011-06-13

4.  Impact of a clinical pharmacy admission medication reconciliation program on medication errors in "high-risk" patients.

Authors:  Mitchell S Buckley; Lisa M Harinstein; Kimberly B Clark; Pamela L Smithburger; Doug J Eckhardt; Earnest Alexander; Sandeep Devabhakthuni; Craig A Westley; Butch David; Sandra L Kane-Gill
Journal:  Ann Pharmacother       Date:  2013-10-15       Impact factor: 3.154

5.  Economic value of pharmacist-led medication reconciliation for reducing medication errors after hospital discharge.

Authors:  Mehdi Najafzadeh; Jeffrey L Schnipper; William H Shrank; Steven Kymes; Troyen A Brennan; Niteesh K Choudhry
Journal:  Am J Manag Care       Date:  2016-10       Impact factor: 2.229

6.  Adverse drug events occurring following hospital discharge.

Authors:  Alan J Forster; Harvey J Murff; Josh F Peterson; Tejal K Gandhi; David W Bates
Journal:  J Gen Intern Med       Date:  2005-04       Impact factor: 5.128

7.  Reconcilable differences: correcting medication errors at hospital admission and discharge.

Authors:  T Vira; M Colquhoun; E Etchells
Journal:  Qual Saf Health Care       Date:  2006-04

8.  The incidence and severity of adverse events affecting patients after discharge from the hospital.

Authors:  Alan J Forster; Harvey J Murff; Josh F Peterson; Tejal K Gandhi; David W Bates
Journal:  Ann Intern Med       Date:  2003-02-04       Impact factor: 25.391

9.  The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada.

Authors:  G Ross Baker; Peter G Norton; Virginia Flintoft; Régis Blais; Adalsteinn Brown; Jafna Cox; Ed Etchells; William A Ghali; Philip Hébert; Sumit R Majumdar; Maeve O'Beirne; Luz Palacios-Derflingher; Robert J Reid; Sam Sheps; Robyn Tamblyn
Journal:  CMAJ       Date:  2004-05-25       Impact factor: 8.262

Review 10.  Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis.

Authors:  Alemayehu B Mekonnen; Andrew J McLachlan; Jo-Anne E Brien
Journal:  BMJ Open       Date:  2016-02-23       Impact factor: 2.692

View more
  2 in total

1.  Differences in medication reconciliation interventions between six hospitals: a mixed method study.

Authors:  C C M Stuijt; B J F van den Bemt; V E Boerlage; M J A Janssen; K Taxis; F Karapinar-Çarkit
Journal:  BMC Health Serv Res       Date:  2022-05-31       Impact factor: 2.908

2.  Revisiting acidosis in acetazolamide treatment of severe glaucoma: A case report.

Authors:  Rachel C Greiner; Heather M Beasley; Hari Bodhireddy; Chad R Bouterse; Mark T Eggleston; David C Pfeiffer
Journal:  Am J Ophthalmol Case Rep       Date:  2022-07-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.